These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 16140916
1. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells. Oka N, Nakahara S, Takenaka Y, Fukumori T, Hogan V, Kanayama HO, Yanagawa T, Raz A. Cancer Res; 2005 Sep 01; 65(17):7546-53. PubMed ID: 16140916 [Abstract] [Full Text] [Related]
2. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells. Kandasamy K, Srivastava RK. Cancer Res; 2002 Sep 01; 62(17):4929-37. PubMed ID: 12208743 [Abstract] [Full Text] [Related]
3. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL). Rychahou PG, Murillo CA, Evers BM. Surgery; 2005 Aug 01; 138(2):391-7. PubMed ID: 16153452 [Abstract] [Full Text] [Related]
4. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Gibson EM, Henson ES, Haney N, Villanueva J, Gibson SB. Cancer Res; 2002 Jan 15; 62(2):488-96. PubMed ID: 11809700 [Abstract] [Full Text] [Related]
5. HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis. Dubská L, Andera L, Sheard MA. FEBS Lett; 2005 Aug 01; 579(19):4149-58. PubMed ID: 16023111 [Abstract] [Full Text] [Related]
6. Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells. Earel JK, VanOosten RL, Griffith TS. Cancer Res; 2006 Jan 01; 66(1):499-507. PubMed ID: 16397266 [Abstract] [Full Text] [Related]
7. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK. Cancer Res; 2003 Apr 01; 63(7):1712-21. PubMed ID: 12670926 [Abstract] [Full Text] [Related]
8. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
9. eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Tong X, Li H. Cancer Lett; 2004 Jul 08; 210(1):63-71. PubMed ID: 15172122 [Abstract] [Full Text] [Related]
10. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Rokhlin OW, Guseva NV, Tagiyev AF, Glover RA, Cohen MB. Prostate; 2002 Jun 01; 52(1):1-11. PubMed ID: 11992615 [Abstract] [Full Text] [Related]
12. Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation. Cho YL, Lee KS, Lee SJ, Namkoong S, Kim YM, Lee H, Ha KS, Han JA, Kwon YG, Kim YM. Biochem Biophys Res Commun; 2005 Jan 28; 326(4):752-8. PubMed ID: 15607733 [Abstract] [Full Text] [Related]
13. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase. Cenni V, Maraldi NM, Ruggeri A, Secchiero P, Del Coco R, De Pol A, Cocco L, Marmiroli S. Int J Oncol; 2004 Dec 28; 25(6):1599-608. PubMed ID: 15547696 [Abstract] [Full Text] [Related]
14. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775 [Abstract] [Full Text] [Related]
15. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK. Oncogene; 2001 Sep 20; 20(42):6073-83. PubMed ID: 11593415 [Abstract] [Full Text] [Related]
16. PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Larribere L, Khaled M, Tartare-Deckert S, Busca R, Luciano F, Bille K, Valony G, Eychene A, Auberger P, Ortonne JP, Ballotti R, Bertolotto C. Cell Death Differ; 2004 Oct 20; 11(10):1084-91. PubMed ID: 15243584 [Abstract] [Full Text] [Related]
17. Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax. Jia L, Patwari Y, Kelsey SM, Newland AC. Biochem Biophys Res Commun; 2001 May 25; 283(5):1037-45. PubMed ID: 11355877 [Abstract] [Full Text] [Related]
18. Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway. Kim KM, Lee YJ. Oncogene; 2005 Jan 13; 24(3):355-66. PubMed ID: 15558024 [Abstract] [Full Text] [Related]
19. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway. Pespeni MH, Hodnett M, Abayasiriwardana KS, Roux J, Howard M, Broaddus VC, Pittet JF. Cancer Res; 2007 Mar 15; 67(6):2865-71. PubMed ID: 17363610 [Abstract] [Full Text] [Related]
20. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related] Page: [Next] [New Search]